6 Similar Sites like Rxcelerate.com

RxCelerate RxCelerate website

Site Popularity:
8 points

Language: English

GEN - Genetic Engineering and Biotechnology News genengnews.com

Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.

Tags: AdvertisementBiotechnologyDiscoveryDrug
Similarity:
45%

Nature nature.com

First published in 1869, Nature is the world's leading multidisciplinary science journal. Nature publishes the finest peer-reviewed research that drives ground-breaking discovery, and is read by thought-leaders and decision-makers around the world.

Tags: AdvertisementBiotechnologyDiscoveryDrug
Similarity:
45%

News from California, the nation and world - Los Angeles Times latimes.com

The L.A. Times is a leading source of breaking news, entertainment, sports, politics, and more for Southern California and the world.

Tags: AdvertisementDrugFill
Similarity:
40%

Law.com law.com

Law.com delivers news, insights and resources that allow legal professionals to anticipate opportunities, adapt to change, and prepare for future success.

Tags: AdvertisementDiscovery
Similarity:
36%

Urgent Need for Pet Adoption - Find Dogs & Cats & More | Petfinder petfinder.com

With more adoptable pets than ever, we have an urgent need for pet adopters. Search for dogs, cats, and other available pets for adoption near you.

Tags: AdvertisementDiscovery
Similarity:
36%

Fierce Biotech News & Reports fiercebiotech.com

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D.

Tags: CroBiotechnologyDrug
Similarity:
28%
Analyzed Keywords
Xo1 Working Website Scien­tific Rxcelera­te Prog­ram­me Phar­maceuti­cal Out­sour­ced Os­teoarthri­tis Novel Models Ltd Levicept Levi Jill Fill Ex­peri­men­tal Endpoints Drug Dis­co­very Deve­lop­ment Develop Cro Clients Cambrid­ge Biotechno­logy Bespoke Babraham Ad­ver­tise­ment Acquires